Please use this identifier to cite or link to this item: https://ahro.austin.org.au/austinjspui/handle/1/25739
Full metadata record
DC FieldValueLanguage
dc.contributor.authorNarayanasamy, Shanti-
dc.contributor.authorNation, Roger L-
dc.contributor.authorMahony, Andrew A-
dc.contributor.authorGrayson, M Lindsay-
dc.contributor.authorKwong, Jason C-
dc.contributor.authorSherry, Norelle L-
dc.contributor.authorKhumra, Sharmila-
dc.contributor.authorEllis, Andrew G-
dc.contributor.authorFrauman, Albert G-
dc.contributor.authorHolmes, Natasha E-
dc.date2020-11-26-
dc.date.accessioned2021-02-01T04:24:35Z-
dc.date.available2021-02-01T04:24:35Z-
dc.date.issued2021-01-
dc.identifier.citationOpen Forum Infectious Diseases 2021; 8(1): ofaa572en
dc.identifier.issn2328-8957
dc.identifier.urihttps://ahro.austin.org.au/austinjspui/handle/1/25739-
dc.description.abstractWe describe a case of limb-threatening osteomyelitis and metalware infection with carbapenemase-producing extensively drug-resistant Pseudomonas aeruginosa successfully cured with aggressive surgical debridement and combined intravenous fosfomycin and colistin. Real-time therapeutic drug monitoring was used to maximize probability of efficacy and minimize potential for toxicity.en
dc.language.isoeng
dc.subjectXDR gram-negativeen
dc.subjectcolistinen
dc.subjectfosfomycinen
dc.subjectosteomyelitisen
dc.subjecttherapeutic drug monitoringen
dc.titleCure of Limb-Threatening XDR Pseudomonas aeruginosa Infection: Combining Genome Sequencing, Therapeutic Drug Level Monitoring, and Surgical Debridement.en
dc.typeJournal Articleen
dc.identifier.journaltitleOpen Forum Infectious Diseasesen
dc.identifier.affiliationDrug Delivery, Disposition and Dynamics, Monash Institute of Pharmaceutical Sciences, Monash University, Parkville, Australiaen
dc.identifier.affiliationDepartment of Medicine, University of Melbourne, Melbourne, Australiaen
dc.identifier.affiliationMicrobiological Diagnostic Unit Public Health Laboratory, Department of Microbiology and Immunology, University of Melbourne at the Doherty Institute for Infection & Immunity, Melbourne, Australiaen
dc.identifier.affiliationClinical Pharmacology and Therapeuticsen
dc.identifier.affiliationPharmacyen
dc.identifier.affiliationInfectious Diseasesen
dc.identifier.doi10.1093/ofid/ofaa572en
dc.type.contentTexten
dc.identifier.orcid0000-0002-6667-2868en
dc.identifier.orcid0000-0003-1492-8590en
dc.identifier.pubmedid33511225
local.name.researcherEllis, Andrew G
item.languageiso639-1en-
item.fulltextNo Fulltext-
item.grantfulltextnone-
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
item.cerifentitytypePublications-
item.openairetypeJournal Article-
crisitem.author.deptInfectious Diseases-
crisitem.author.deptInfectious Diseases-
crisitem.author.deptInfectious Diseases-
crisitem.author.deptInfectious Diseases-
crisitem.author.deptPharmacy-
crisitem.author.deptMedicine (University of Melbourne)-
crisitem.author.deptClinical Pharmacology and Therapeutics-
crisitem.author.deptInfectious Diseases-
crisitem.author.deptData Analytics Research and Evaluation (DARE) Centre-
Appears in Collections:Journal articles
Show simple item record

Page view(s)

112
checked on Dec 20, 2024

Google ScholarTM

Check


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.